| Synonyms |
Blonanserin;CYCLOOCTA[B]PYRIDINE, 2-(4-ETHYL-1-PIPERAZINYL)-4-(4-FLUOROPHENYL)-5,6,7,8,9,10-HEXAHYDRO-;AD 5423;2-(4-Ethyl-1-piperazinyl)-4-(4-fluorophenyl)-5,6,7,8,9,10-hexahydrocycloocta[b]pyridine;2-(4-Ethylpiperazin-1-yl)-4-(4-fluorophenyl)-5,6,7,8,9,10-hexahydrocycloocta[b]pyridine;Lonasen;Blonansarin –;Blonanserin, AD-5423, Lonasen;Blonansarin;Blonanserin;Blonanserin,AD5423;AD-5423;Blonanserin-d8 HCl;6-broMo-4,8-dichloro-5-Methoxyquinoline;5-HT2 receptor antagonist;Blonanserin [INN];Blonanserin (Lonasen);AQ316B4F8C;2;CHEBI:31296;DSP-5423;132810-10-7 (free base);DTXCID3028716;s2112;2-(4-ethylpiperazin-1-yl)-4-(4-fluorophenyl)-5,6,7,8,9,10-hexahydrocycloocta[b]pyridine.;CAS-132810-10-7;AD5423;2-(4-ethyl-1-piperazinyl)-4-(4-fluorophenyl)-5,6,7,8,9,10-hexahydrocycloocta[b]pyridine;Blonanserin (JAN/INN);FT-0663415;NS00068341;PDSP2_000710;2-(4-Ethyl-1-piperazinyl)-4-(p-fluorophenyl)-5,6,7,8,9,10-hexahydrocycloocta(b)pyridine;PDSP1_000720;AC-1599;Blonanserin, >=98% (HPLC);CHEMBL178803;SR-01000945256-1;132810-10-7;4-(4-Fluoro-phenyl)-2-(4-propyl-piperazin-1-yl)-5,6,7,8,9,10-hexahydro-cycloocta[b]pyridine;HY-13575;BLONANSERIN [WHO-DD];UNII-AQ316B4F8C;2-(4-ethylpiperazin-1-yl)-4-(4-fluorophenyl)-5,6,7,8,9,10-hexahydrocycloocta[b]pyridine;NCGC00183858-01;Q4927426;SB17396;Cycloocta(b)pyridine, 2-(4-ethyl-1-piperazinyl)-4-(1-fluorophenyl)-5,6,7,8,9,10-hexahydro-;BLONANSERIN [MI];D01176;Cycloocta(b)pyridine, 2-(4-ethyl-1-piperazinyl)-4-(4-fluorophenyl)-5,6,7,8,9,10-hexahydro-;BDBM50160807;SCHEMBL119669;EX-A663;BLONANSERIN [JAN];Tox21_113267;AKOS005145823;HMS3740E13;DTXSID7048790;BCP04236;2-(4-ETHYLPIPERAZIN-1-YL)-4-(4-FLUOROPHENYL)-5,6,7,8,9,10-HEXAHYDROCYCLOOCTA(B)PYRIDINE;GTPL7670;B4565;AB01565798_02;SR-01000945256;DB09223;AS-11421;2-(4-Ethyl-1-piperazinyl)-4-(4-fluorophenyl)-5,6,7,8,9,10-hexahydrocycloocta(b)pyridine;C23H30FN3;Blonanserin(AD-5423);BLONANSERIN [MART.];MFCD00893838;L001392;AMY8830 |
COA
